Size and fit

The Nike Roshe Two Flyknit is a shoe for men and women. It fairly runs true to size. Nike’s online store uses True Fit. It’s a platform that allows users to purchase their normal size based on sizing data from other brands.

The lace-up closure allows a custom, snug fit. The Flyknit upper is adaptive and hugs the foot like a sock. It also has an inner sleeve construction that delivers a snug and comfy feel. The collar is padded for plush cushioning.

Nike Roshe Two Flyknit Style

The Nike Roshe Two Flyknit is a low-top lifestyle shoe with performance features. It features the company’s Flyknit technology, an updated midsole and a sock-like construction. The shoe embodies simplicity through minimalism. There are no decorations.

The design is a contrast of playfulness and seriousness. The shoe drew inspiration from the Zen concept and meditation. It’s great whether the user is dressed down or dressed up.

Notable Features

Most people were impressed with how comfortable the Nike Roshe Two Flyknit is. The soft comfort of the shoe comes from the Flyknit upper and the three layers of cushioning. The midsole has three foam densities that provide excellent cushioning the entire day. It also has a sockliner made of amazingly soft foam that improves underfoot ease.

Nike Roshe Two Flyknit History

The Roshe Two Flyknit is the second silhouette from Nike’s Roshe series. The Flyknit version was released globally on September 1, 2016, initially in two colorways. Its predecessor, the Roshe One, is a popular shoe that even reached the top spot of an eBay list.

The Roshe line started with a running shoe called Nike Roshe Run released in 2012. Its designer Dylan Raasch got the inspiration from Zen Buddhist gardens which have a simple and balanced aesthetic. The name Roshe comes from the Rōshi title given to Zen Buddhist masters. For legal purposes, Nike changed the name.

The runner retailed for 70 USD. When it was released, Nike didn’t run any campaign to promote the shoe. There were no advertisements or endorsements by celebrities or athletes. Regardless of the lack of publicity, it received a warm welcome from the sneaker community and the public.

The Flyknit technology applied to the second version of the Nike Roshe is the answer to runners who wanted a snug fit that feels like a sock. The American footwear giant spent more than ten years looking for the next footwear evolution until they came up with the Flyknit Racer in 2012. The creation was an effort made by designers, engineers and programmers. They came up with a knit upper that is durable and structured with its static qualities.

The team also refined the accurate placement of breathability, support and flexibility in a single layer. This application used athlete insights gathered by Nike for 40 years. The components are placed where athletes need it. The outcome is a lightweight, custom-fitting and virtually seamless upper.

Nike prides itself in its progressive way of manufacturing footwear that allows designers to micro-engineer each stitch in a precise manner while lessening the number of materials used and factory waste.

Additional Info

  • The Roshe Two Flyknit has an updated version called Roshe Two Flyknit V2, which has slight changes to its construction. The typical tongue was transformed into a sock-like collar. Another difference is the finer lines of the ribbed weave. The shoe was released just in time for summer 2017.
  • The shoe has a waffle-like outsole.
  • The Roshe Two Flyknit upper shifts between two colors while the wearer moves.
  • The tongue and the ankle collar have adequate padding for enhanced comfort.
  • There are pull tabs in the heel and tongue for ease of entry and exit.


The current trend of Nike Roshe Two Flyknit.
Compare to another shoe:
Danny McLoughlin
Danny McLoughlin

Danny is a sports nut with a particular interest in football and running. He loves to watch sports as much as he loves to play. Danny was lead researcher on RunRepeat and The PFA’s report into Racial Bias in Football Commentary. His football and running research has been featured in The Guardian, BBC, New York Times and Washington Post.